Navigation Links
ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
Date:6/17/2008

LEUVEN, Belgium, LUND, Sweden and BASEL, Switzerland, June 18 /PRNewswire-FirstCall/ -- ThromboGenics NV (Euronext Brussels: THR) and BioInvent International AB (Nordic Exchange: BINV) announce that they have entered into a license agreement with Roche (SWX: ROG) for their jointly developed anti-cancer agent TB-403. TB-403 is a novel monoclonal antibody which blocks Placental Growth Factor (PIGF), one of the growth factors responsible for the development of new blood vessels.

Under the terms of the agreement effective from June 17, 2008 (or if a U.S. anti-trust clearance is required, from the date of receipt of such clearance), Roche will pay ThromboGenics and BioInvent an upfront payment of EUR50 million. In addition, ThromboGenics and BioInvent could potentially receive up to EUR450 million over the term of the collaboration based on the successful completion of a series of development and commercial milestones for multiple indications, as well as double digit royalties on potential product sales, including any backup antibodies based on inhibition of PlGF. ThromboGenics, which discovered TB-403, will receive 60% and BioInvent 40% of the revenue from the deal. Roche will have a worldwide, exclusive license to develop and commercialize TB-403. ThromboGenics and BioInvent will retain co-promotion rights for the product in the Benelux, Baltic and Nordic regions.

ThromboGenics and BioInvent are responsible for any remaining costs associated with the recently completed Phase Ia trial in healthy volunteers. Roche will assume responsibility for all future development costs for this novel therapy, including the costs of the pending Phase Ib trial in patients to be run by ThromboGenics and BioInvent. ThromboGenics and BioInvent in conjunction with Roche will form a Joint Steering Committee to oversee research and development activities. In addition, Roche will also provide funding to ThromboGenics and BioInvent for research on non-cancer indications an
'/>"/>

SOURCE ThromboGenics NV
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007
2. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
3. ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402
4. ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell
5. ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
6. ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting
7. ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer
8. ThromboGenics Announces 2007 Full Year Results
9. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
10. ThromboGenics N.V. - Business Update
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2008)...HILL, N.C., Oct. 9 /- Pairing traditi...tworking and multi-channel marketing,are helping o...ons and stay,afloat financially in today,s market....s in Recessions, the 10th annual quality excellenc...L BENCHMARKING COUNCIL,executives from leading co...
(Date:10/9/2008)...umber 7 out of top 20 Employers Across Life Scienc...e/ -- EMD Serono, Inc., an affiliate,of Merck KGaA...been named,by Science magazine as a top employer i... ranking number 7 out of the top 20 employers,acro...cientific community has recognized EMD Serono,as a...
(Date:10/9/2008)...PTON, Pa., Oct. 9 /- Enviro...C" or the "Company") BioMedical,Division today ann...) XD,Monoplace Hyperbaric Chambers to Comprehensiv...hcare Solutions, a growing company who focuses,sol...itutes throughout the,United States, has purchased...
(Date:10/9/2008)...s to be used to support the achievement of several...stones of Acasti Pharma, LAVAL, QC, Oct. 9 /PRNew...ne Technologies & Bioressources Inc. ("Neptune") (...Company successfully completed as of,October 8, 20...debentures,for gross proceeds of $2,750,000., The...
Breaking Biology Technology:Six Sigma and Social Media: Tools for Reducing Costs, Improving Processes 2EMD Serono Named as a Top Employer by Science Magazine 2Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions 2Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions 3Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions 4Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 2Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 3Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 4
...Menasha Advantage, a subsidiary of Neenahs Menasha...ely calls The Skunkworks. There, a better cardboar...ency Identification technology, Menasha Advantage ...nd of a supply chain to another. The Internet-base...orporate managers and enhance safety in an era wh...
...ion , ,Identity theft has seen the largest increa...ears. The United States is faced with an ever-chan...ter security on both sides of the equation, organi...e list of consumer complaints, according to a new ...ased on the FTC figures, approximately 700,000 peo...
...ply to Academics , ,MADISON-WI. - The Wisconsin T..., Ph.D , a University of Wisconsin-Madison researc... the principles behind learning a game can be used...y hired at the University of Wisconsin-Madison to ...mer elementary and Montessori teacher, Dr. Squire ...
...hat makes you smile, and wish youd been in that ba...developer of computer games, has come from two bro...to being acquired by the second-largest game produ...ous hit games, Raven Software is a dream come true...hers who had backgrounds in art, decided to chuck ...
Other Biology Technology:E-Commerce Skunkworks in Menhasa 2E-Commerce Skunkworks in Menhasa 3Are You Ready for Identity Theft? 2Are You Ready for Identity Theft? 3Are You Ready for Identity Theft? 4Are You Ready for Identity Theft? 5Are You Ready for Identity Theft? 6Are You Ready for Identity Theft? 7GameBased Learning Strategies 2GameBased Learning Strategies 3Its All Fun And Games in Madison - Raven Software Celebrates 15 Anniversary 2Its All Fun And Games in Madison - Raven Software Celebrates 15 Anniversary 3
(Date:10/10/2008)...LLAHASSEE, Fla. -- In a groundbreaking study led b...University, researchers have discovered that as em... there are dramatic corresponding changes to the o..., The findings bridge a critical knowledge gap fo...derstand the enormously complex process by which D...
(Date:10/10/2008)...DA, MD October 7, 2008 The world,s top scientist... gather in Philadelphia to present their latest re...,American Society of Human Genetics (ASHG) from Tu..., 2008, at the Pennsylvania Convention Center., F...embership organization for human genetics,special...
(Date:10/10/2008)... Yamanaka MD, PhD, of Kyoto University and the Gla...has taken another step forward in improving the po...ed pluripotent stem (iPS) cell technology. , Pre...an be reprogrammed to become embryonic stem cellli...our genes required to reprogram the cells, and a v...
(Date:10/10/2008)...chers from the Peninsula Medical School in Plymout... one hour of moderate exercise a day recommended t...o tackle the rising problem of childhood obesity. ...recent issue of the journal "Archives of Diseases ...Bird study, which has followed the development of ...
Breaking Biology News(10 mins):Landmark study unlocks stem cell, DNA secrets to speed therapies 2Landmark study unlocks stem cell, DNA secrets to speed therapies 3The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 2The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 3The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 4The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 5Yamanaka eliminates viral vector in stem cell reprogramming 2Recommendations for children's exercise lacking say experts 2Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 1Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 2Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 3Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 4Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 5Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 4592 1Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 4592 2Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 4592 3Kiadis Pharma Receives Orphan Drug Designation for Rhitol 28TM 29 From the FDA 4587 1Kiadis Pharma Receives Orphan Drug Designation for Rhitol 28TM 29 From the FDA 4587 2Clinical guidelines for the manual titration of PAP in OSA patients published in JCSM 16796 1Clinical guidelines for the manual titration of PAP in OSA patients published in JCSM 16796 2
...preads, people often die. That,s why a lot of canc...ays that allow cancer to metastasize -- to spread ...niversity researchers have now furthered understan...ght aid future research on drug therapies that dis...s. , A study published in the journal Developmenta...
...rom the University of Pennsylvania School of Medic...veral genes known to regulate the development of h...stem cells, in bone marrow. Knowing the details of...or such blood diseases as leukemia, as well as a b...t of bone-marrow and peripheral-stem-cell transpla...
...cial for the development of strong, healthy crops....ved in the development of roots was still a myster...stitute for Biotechnology (VIB) connected to Ghent...ome in order to identify the genes that are essent...first time, they are unraveling the genetic basis ...
...rinarians and meat processors who routinely come i...y increased risk of infection with flu viruses tha... by the National Institute of Allergy and Infectio...s of Health (NIH). , While the findings are not e...infection coupled with the fact that pigs can be i...
Other Biology News:Researcher uncovers details of how cancer spreads 2Master regulatory gene found that guides fate of blood-producing stem cells 2Plant genes identified that can form basis for crops better adapted to environmental conditions 2Agricultural workers at increased risk for infection with animal flu viruses 2Agricultural workers at increased risk for infection with animal flu viruses 3
...ostics Cytomegalovirus (CMV) pp65 Antigenemia Immu...litative identification of lower matrix protein pp... Kit Components: Erythrocyte Lysis Buffer - (...buffered ammonium chloride. (NH4CL) Fixation Solu...
The CultureWell cell culture systems provide an integrated set-up for preparing cultured cells for staining and imaging. Each system uses medical-grade silicone gaskets preassembled with standard opt
nuclear cap binding protein subunit 1, 80kDa, mRNA
GOAT ANTI SLI
Biology Products: